Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 4.04% |
UNITEDHEALTH GROUP INC. | UNH | 3.55% |
JOHNSON & JOHNSON | JNJ | 2.98% |
MERCK & COMPANY, INC. | MRK | 2.95% |
ABBVIE INC | ABBV | 2.70% |
THERMO FISHER SCIENTIFIC | TMO | 2.25% |
ABBOTT LABORATORIES | ABT | 2.07% |
DANAHER CORPORATION | DHR | 2.02% |
AMGEN INC. | AMGN | 1.94% |
PFIZER INC | PFE | 1.93% |
ELEVANCE HEALTH INC | ANTM | 1.87% |
INTUITIVE SURGICAL, INC. | ISRG | 1.82% |
THE CIGNA GROUP | CI | 1.68% |
STRYKER CORP | SYK | 1.67% |
BOSTON SCIENTIFIC CORP | BSX | 1.64% |
VERTEX PHARMACEUTICALS | VRTX | 1.63% |
BRISTOL MYERS SQUIBB CO | BMY | 1.56% |
REGENERON PHARMACEUTICALS | REGN | 1.55% |
CVS HEALTH CORP. | CVS | 1.50% |
GILEAD SCIENCES, INC. | GILD | 1.42% |
ASTRAZENECA PLC ADR | AZN | 1.42% |
MCKESSON CORPORATION | MCK | 1.35% |
BECTON DICKINSON & CO | BDX | 1.34% |
MEDTRONIC PLC | MDT | 1.24% |
ZOETIS INC | ZTS | 1.21% |
HCA HEALTCARE INC | HCA | 1.19% |
DEXCOM INC | DXCM | 1.19% |
EDWARDS LIFESCIENCES CORP | EW | 1.12% |
CENCORA INC | ABC | 1.06% |
HUMANA, INC. | HUM | 1.01% |
CENTENE CORP | CNC | 0.99% |
IQVIA HOLDINGS INC | IQV | 0.97% |
NOVO-NORDISK A/S -ADR | NVO | 0.97% |
MODERNA INC | MRNA | 0.97% |
AGILENT TECHNOLOGIES, INC | A | 0.96% |
IDEXX LABORATORIES INC | IDXX | 0.94% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.94% |
ICON PLC | ICLR | 0.90% |
WEST PHARMACEUTICAL SERVI | WST | 0.89% |
ARGENX SE - ADR | ARGX | 0.84% |
VEEVA SYSTEMS-A | VEEV | 0.83% |
NOVARTIS ADR | NVS | 0.81% |
BIOGEN IDEC, INC. | BIIB | 0.81% |
GSK PLC-SPON ADR | GSK-W | 0.81% |
CARDINAL HEALTH, INC. | CAH | 0.81% |
TEVA PHARMACEUTICAL | TEVA | 0.80% |
RESMED INC | RMD | 0.79% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.79% |
ALKERMES PLC | ALKS | 0.74% |
ALIGN TECHNOLOGY | ALGN | 0.74% |
MOLINA HEALTHCARE INC | MOH | 0.73% |
BAXTER INTERNATIONAL | BAX | 0.71% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.70% |
ALNYLAM PHARMACEUTICALS | ALNY | 0.69% |
HOLOGIC, INC. | HOLX | 0.68% |
ILLUMINA INC | ILMN | 0.66% |
COOPER COS INC/THE | COO | 0.65% |
AVANTOR INC | AVTR | 0.65% |
LABORATORY CORP OF AMERIC | LH | 0.64% |
CRISPR THERAPEUTICS AG | CRSP | 0.64% |
METTLER-TOLEDO INTERNATIO | MTD | 0.63% |
WATERS CORPORATION | WAT | 0.62% |
QUEST DIAGNOSTICS, INC. | DGX | 0.61% |
SHOCKWAVE MEDICAL INC | SWAV | 0.60% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.60% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.59% |
VIATRIS INC | VTRS | 0.57% |
EXACT SCIENCES | EXAS | 0.55% |
UNITED THERAPEUTICS CORP | UTHR | 0.54% |
SAREPTA THERAPEU | SRPT | 0.52% |
INSULET CORP | PODD | 0.52% |
CATALENT INC | CTLT | 0.51% |
NATERA INC | NTRA | 0.50% |
INCYTE CORP | INCY | 0.49% |
UNIVERSAL HEALTH SERVICES | UHS | 0.48% |
HENRY SCHEIN, INC. | HSIC | 0.47% |
TENET HEALTHCARE CORP | THC | 0.47% |
BIO-TECHNE CORP | TECH | 0.46% |
CYTOKINETICS INC | CYTK | 0.44% |
INTRA-CELLULAR T | ITCI | 0.43% |
INSPIRE MEDICAL SYSTEMS I | INSP | 0.43% |
MASIMO CORP | MASI | 0.43% |
EXELIXIS, INC. | EXEL | 0.43% |
HEALTHEQUITY INC | HQY | 0.43% |
REPLIGEN CORP | RGEN | 0.42% |
REVOLUTION MEDICINES INC | RVMD | 0.41% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.41% |
BRUKER CORP | BRKR | 0.40% |
PENUMBRA INC | PEN | 0.40% |
MEDPACE HOLDINGS | MEDP | 0.40% |
DENTSPLY SIRONA, NC. | XRAY | 0.39% |
DAVITA, INC | DVA | 0.39% |
ACADIA HEALTHCAR | ACHC | 0.38% |
OPTION CARE HEALTH INC | OPCH | 0.37% |
IONIS PHARMACEUTICALS, IN | IONS | 0.36% |
BLUEPRINT MEDICI | BPMC | 0.35% |
ROIVANT SCIENCES LTD | ROIV | 0.35% |
HALOZYME THERAPEUTICS INC | HALO | 0.34% |
LANTHEUS HOLDING | LNTH | 0.34% |
APELLIS PHARMACE | APLS | 0.32% |
ULTRAGENYX PHARM | RARE | 0.28% |
BRIDGEBIO PHARMA INC | BBIO | 0.28% |
AXSOME THERAPEUT | AXSM | 0.25% |
AZENTA INC | BRKS | 0.24% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.23% |
TELADOC HEALTH INC | TDOC | 0.22% |
INARI MEDICAL INC | NARI | 0.22% |
R1 RCM INC | RCM | 0.21% |
GUARDANT HEALTH INC | GH | 0.20% |
TG THERAPEUTICS | TGTX | 0.20% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.20% |
MADRIGAL PHARMAC | MDGL | 0.14% |
Other (Cash, derivatives and other liabilities) | 0.03% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.